Global Health Technologies Coalition Global Health Technologies Coalition
  • Why R&D
  • R&D Facts
  • In Your State
  • Solutions
  • Breakthroughs Blog
  • News & Events
  • Resources
  • About Us
Stay Informed

Breakthroughs Blog

Breakthroughs brings you stories of bright ideas and bold innovations in global health.

From the Breakthroughs Blog: Page #1

Research Roundup: NIAID begins new antibody trials, convalescent plasma may lower COVID-19 risk, and Pfizer vaccine appears effective against mutation
PATH/Eric Becker
January 11, 2021

Research Roundup: NIAID begins new antibody trials, convalescent plasma may lower COVID-19 risk, and Pfizer vaccine appears effective against mutation

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
Six issues to watch in US global health R&D policy in 2021
IAEA imagebank, NLO Office, Syrian Arab Republic
January 5, 2021

Six issues to watch in US global health R&D policy in 2021

2021 is shaping up to be an extraordinarily consequential year for US policy for global health and medical research, as a new presidential administration and Congress take charge against the backdrop of a global pandemic that has killed 1.6 million people worldwide and set back decades of progress in global health. As 2021 begins, here are some of the top policy issues GHTC will be tracking.
Marissa Chmiola GHTC
Read more
Research Roundup: AstraZeneca shot gets first authorization, WHO issues emergency validation for Pfizer vaccine, and second Ebola drug gets FDA approval
PATH/Rocky Prajapati
January 4, 2021

Research Roundup: AstraZeneca shot gets first authorization, WHO issues emergency validation for Pfizer vaccine, and second Ebola drug gets FDA approval

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
Research Roundup: Moderna shot gets EUA, 2 monoclonal antibody treatments enter phase 3 trials, and first at-home, over-the-counter COVID-19 diagnostic gets EUA
PATH/Rocky Prajapati
December 21, 2020

Research Roundup: Moderna shot gets EUA, 2 monoclonal antibody treatments enter phase 3 trials, and first at-home, over-the-counter COVID-19 diagnostic gets EUA

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
Research Roundup: Pfizer shot gets EUA, vaccine inequity threatens global COVID-19 fight, and drug developers pursue COVID-19 therapeutics
PATH/Rocky Prajapati
December 14, 2020

Research Roundup: Pfizer shot gets EUA, vaccine inequity threatens global COVID-19 fight, and drug developers pursue COVID-19 therapeutics

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
Research Roundup: UK approves Pfizer vaccine, the question of pregnant health care workers in vaccine distribution, and a quantitative antibody test
PATH/Aaron Joel Santos
December 7, 2020

Research Roundup: UK approves Pfizer vaccine, the question of pregnant health care workers in vaccine distribution, and a quantitative antibody test

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
  • 1
  • 2
  • 3
  • 4
  • 5
  • ....
  • Next
advancing innovation to save lives

© 2009–2021, PATH, as secretariat of the Global Health Technologies Coalition.
Header Photo: PATH/Evelyn Hockstein

  • Stay Informed
  • Join Us
  • Contact Us
  • GHTC Member Log In